Korro Bio Stock Quote KRRO - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

58.01

Bid

57.24

Ask

58.23

Volume

6,419

54.44 Day's Range 58.01

13.00 52 Week Range 97.91

Market Cap

41.424M

Previous Close

56.79

Open

55.00

Last Trade

57.9289

Last Trade Time

11:46:50

Financial Volume

$ 354,875

VWAP

55.2851

Average Volume (3m)

34,777

Shares Outstanding

738,526

Dividend Yield

PE Ratio

-0.51

Earnings Per Share (EPS)

-109.91

Revenue

Net Profit

-81.17M

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.korrobio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Korro Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRRO. The last closing price for Korro Bio was $56.79. Over the last year, Korro Bio shares have traded in a share price range of $ 13.00 to $ 97.91.

Korro Bio currently has 738,526 shares outstanding. The market capitalization of Korro Bio is $41.42 million. Korro Bio has a price to earnings ratio (PE ratio) of -0.51.

Korro Announces $70 Million Private Placement

Financing led by Deep Track Capital with participation from other leading healthcare investors Pro-forma cash and cash equivalents of approximately $236 million before fees and expenses On track...

Korro to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., Chief Financial Officer...

Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress

On track for regulatory filing for First-in-Human study of KRRO-110 in Alpha-1 Antitrypsin Deficiency (AATD) patients anticipated in the second half of 2024Demonstrated the versatility of Korro’s...

Korro to Present at the TD Cowen 44th Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., will present at the TD...

Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio

KRRO-110 has a potentially best-in-class profile with secretion of ~50µM functional AAT protein after a single dose in a preclinical mouse modelEvidence of greater than 40% editing of SERPINA1 RNA...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-9.81	-14.4647596579	67.82	67.82	54.44	31111	59.856091	CS
4	-22.87	-28.2764589515	80.88	82.225	54.44	36143	69.66623094	CS
12	-3.21	-5.24338451486	61.22	97.91	46.02	34777	66.08303539	CS
26	45.01	346.230769231	13	97.91	13	44431	53.68905442	CS
52	45.01	346.230769231	13	97.91	13	44431	53.68905442	CS
156	45.01	346.230769231	13	97.91	13	44431	53.68905442	CS
260	45.01	346.230769231	13	97.91	13	44431	53.68905442	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CTMXCytomX Therapeutics Inc	$ 4.7829 (193.43%)	128.29M
SYTSYLA Technologies Company Ltd	$ 3.73 (155.48%)	5.24M
AKANAkanda Corporation	$ 0.123 (32.26%)	159.32M
STISolidion Technology Inc	$ 2.7774 (32.26%)	1.16M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.3659 (30.03%)	5.29M
CETXCemtrex Inc	$ 0.3101 (-72.80%)	13.88M
CVRXCVRx Inc	$ 9.17 (-40.88%)	924.55k
BENFBeneficient	$ 2.3601 (-28.91%)	112.26k
MNDRMobile health Network Solutions	$ 17.94 (-27.22%)	923.93k
CGCCanopy Growth Corporation	$ 11.2094 (-24.67%)	34.85M
AKANAkanda Corporation	$ 0.123 (32.26%)	159.32M
CTMXCytomX Therapeutics Inc	$ 4.7829 (193.43%)	128.29M
SQQQProShares UltraPro Short QQQ	$ 12.135 (1.55%)	66.22M
TLRYTilray Brands Inc	$ 2.025 (-18.02%)	60.4M
AMDAdvanced Micro Devices Inc	$ 144.60 (-8.70%)	43.95M